ArticleAmerican heart journal plus : cardiology research and practice2026
Cardiovascular outcomes with semaglutide versus tirzepatide in patients with obesity and atherosclerotic cardiovascular disease without diabetes.
Mohamed Doma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.